Pure Global AI
NCT06323291Recruiting

Cancer Coaching and Remote Education for Self-Empowerment (CARES) Study

H. Lee Moffitt Cancer Center and Research InstitutePhase 1ClinicalTrials.govbehavioral
Verified
Study focus
Disease/Condition
Pancreatic Cancer
Drug/Device/Intervention
Coaching Sessions
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
H. Lee Moffitt Cancer Center and Research Institute
Location
Tampa, United States of America
Timeline & enrollment
Phase
Phase 1
Start date
Apr 01, 2024
End date
Mar 01, 2026
Enrollment
20 participants
Primary outcome

Recruitment Rate,Participant Acceptance of the Digital Health Coaching Program,Participant Ease of Usability of the Digital Health Coaching Program,Feasibility of Utilizing the Digital Health Coaching Program

Summary

This Pilot Study will evaluate a 12-week pilot program that offers digital health coaching
 for individuals with pancreatic cancer and their caregivers.

ICD-10 classifications
Malignant neoplasm of pancreasMalignant neoplasm: Pancreas, unspecifiedMalignant neoplasm: Head of pancreasMalignant neoplasm: Tail of pancreasMalignant neoplasm: Other parts of pancreas
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06323291
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06323291 through Pure Global AI's free database. This Phase 1 trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute and is currently Recruiting. The study focuses on Pancreatic Cancer. Target enrollment is 20 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.